In the world of infectious disease research and development, professionals can’t afford to base their work on biosafety inaccuracies—and as the often-botched response to COVID-19 indicated, the public should be intolerant of such errors, as well.
![]()
Date:
In the world of infectious disease research and development, professionals can’t afford to base their work on biosafety inaccuracies—and as the often-botched response to COVID-19 indicated, the public should be intolerant of such errors, as well.
![]()